Positive and negative associations of HLA class i alleles with allopurinol-induced SCARs in Koreans

Pharmacogenetics and Genomics

Volumn 21, Issue 5, 2011, Pages 303-307

  Kang, Hye Ryun ^a,b   Jee, Young Koo ^d   Kim, Yon Soo ^a   Lee, Chang Hwa ^a   Jung, Jae Woo ^a,b   Kim, Sae Hoon ^a,b   Park, Heung Woo ^a,b   Chang, Yoon Seok ^a,b   Jang, In Jin ^c   Cho, Sang Heon ^a,b   Min, Kyung Up ^a,b   Kim, Sang Heon ^a   Lee, Kyung Wha ^e  

^a Hanyang University   (South Korea)

^b Inst Allerg Clin Immunol M   (South Korea)

^c Seoul National University   (South Korea)

^d Dankook University   (South Korea)

^e Hallym University Sacred Heart Hospital   (South Korea)

Author keywords

allopurinol; drug induced hypersensitivity syndrome; human leukocyte antigen class I; Stevens Johnson syndrome; toxic epidermal necrolysis

Indexed keywords

ALLOPURINOL; HLA ANTIGEN CLASS 1; HLA B ANTIGEN;

ADULT; AGED; ALLELE; ARTICLE; DRESS SYNDROME; FEMALE; GENETIC MARKER; GENOTYPE; HLA TYPING; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; STEVENS JOHNSON SYNDROME; TOXIC EPIDERMAL NECROLYSIS;

EID: 79955464425     PISSN: 17446872     EISSN: 17446880     Source Type: Journal    
DOI: 10.1097/FPC.0b013e32834282b8     Document Type: Article

References (14)

1. Gutierrez-Macias A, Lizarralde-Palacios E, Martinez-Odriozola P, Miguel-De la Villa F. Fatal allopurinol hypersensitivity syndrome after treatment of asymptomatic hyperuricaemia. BMJ 2005; 331:623-624. (Pubitemid 41360781)
2. Halevy S, Ghislain PD, Mockenhaupt M, Fagot JP, Bouwes Bavinck JN, Sidoroff A, et al. Allopurinol is the most common cause of Stevens-Johnson syndrome and toxic epidermal necrolysis in Europe and Israel. J Am Acad Dermatol 2008; 58:25-32. (Pubitemid 350298142)
3. Shalom R, Rimbroth S, Rozenman D, Markel A. Allopurinol-induced recurrent DRESS syndrome: pathophysiology and treatment. Ren Fail 2008; 30:327-329. (Pubitemid 351431217)
4. Chan SH, Tan T. HLA and allopurinol drug eruption. Dermatologica 1989; 179:32-33. (Pubitemid 19172335)
5. Hung SI, Chung WH, Liou LB, Chu CC, Lin M, Huang HP, et al. HLAB* 5801. allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol. Proc Natl Acad Sci USA 2005; 102:4134-4139. (Pubitemid 40388568)
6. Kaniwa N, Saito Y, Aihara M, Matsunaga K, Tohkin M, Kurose K, et al. HLA-B locus in Japanese patients with anti-epileptics and allopurinol-related Stevens-Johnson syndrome and toxic epidermal necrolysis. Pharmacogenomics 2008; 9:1617-1622.
7. Lonjou C, Borot N, Sekula P, Ledger N, Thomas L, Halevy S, et al. A European study of HLA-B in Stevens-Johnson syndrome and toxic epidermal necrolysis related to five high-risk drugs. Pharmacogenet Genomics 2008; 18:99-107.
8. Lee KW, Oh DH, Lee C, Yang SY. Allelic and haplotypic diversity of HLA-A, -B, -C, -DRB1, and -DQB1 genes in the Korean population. Tissue Antigens 2005; 65:437-447. (Pubitemid 40592937)
9. French LE. Toxic epidermal necrolysis and Stevens Johnson syndrome: our current understanding. Allergol Int 2006; 55:9-16.
10. Shiohara T, Iijima M, Ikezawa Z, Hashimoto K. The diagnosis of a DRESS syndrome has been sufficiently established on the basis of typical clinical features and viral reactivations. Br J Dermatol 2007; 156:1083-1084. (Pubitemid 46642847)
11. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988; 16:1215.
12. Hung SI, Chung WH, Jee SH, Chen WC, Chang YT, Lee WR, et al. Genetic susceptibility to carbamazepine-induced cutaneous adverse drug reactions. Pharmacogenet Genomics 2006; 16:297-306.
13. Tassaneeyakul W, Jantararoungtong T, Chen P, Lin PY, Tiamkao S, Khunarkornsiri U, et al. Strong association between HLA-B*5801 and allopurinol-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in a Thai population. Pharmacogenet Genomics 2009; 19:704-709.
14. Kano Y, Hirahara K, Asano Y, Shiohara T. HLA-B allele associations with certain drugs are not confirmed in Japanese patients with severe cutaneous drug reactions. Acta Derm Venereol 2008; 88:616-618.